NO996519L - Doseringsformer av sertralin med forsinket frigjøring - Google Patents

Doseringsformer av sertralin med forsinket frigjøring

Info

Publication number: NO996519L
Authority: NO; Norway
Prior art keywords: dosage forms; delayed release; release sertraline; sertraline; delayed
Prior art date: 1997-07-01

Application number

NO996519A

Other languages

English (en)

Other versions

NO996519D0 (no

Inventor

William John Curatolo

Hylar Lewis Friedman

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1999-12-28

Publication date

2000-02-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO996519(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-12-28 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

1999-12-28 Publication of NO996519D0 publication Critical patent/NO996519D0/no

2000-02-29 Publication of NO996519L publication Critical patent/NO996519L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Addiction (AREA)
Molecular Biology (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Biophysics (AREA)
Pain & Pain Management (AREA)
Gynecology & Obstetrics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO996519A 1997-07-01 1999-12-28 Doseringsformer av sertralin med forsinket frigjøring NO996519L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5149997P	1997-07-01	1997-07-01
PCT/IB1998/000937 WO1999001122A1 (en)	1997-07-01	1998-06-16	Delayed-release dosage forms of sertraline

Publications (2)

Publication Number	Publication Date
NO996519D0 NO996519D0 (no)	1999-12-28
NO996519L true NO996519L (no)	2000-02-29

Family

ID=21971681

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO996519A NO996519L (no)	1997-07-01	1999-12-28	Doseringsformer av sertralin med forsinket frigjøring

Country Status (40)

Country	Link
EP (1)	EP1007024B1 (no)
JP (1)	JP3786715B2 (no)
KR (1)	KR100369698B1 (no)
CN (4)	CN1151783C (no)
AP (1)	AP1199A (no)
AR (1)	AR038394A2 (no)
AT (1)	ATE245415T1 (no)
AU (1)	AU727152B2 (no)
BG (1)	BG64742B1 (no)
BR (1)	BR9809895A (no)
CA (1)	CA2290969C (no)
DE (1)	DE69816624T2 (no)
DK (1)	DK1007024T3 (no)
DZ (1)	DZ2547A1 (no)
EA (1)	EA001906B1 (no)
ES (1)	ES2202858T3 (no)
GT (1)	GT199800091A (no)
HN (1)	HN1998000099A (no)
HR (1)	HRP980376B1 (no)
HU (1)	HUP0301787A3 (no)
ID (1)	ID23187A (no)
IL (2)	IL152304A0 (no)
IS (1)	IS5267A (no)
MA (1)	MA24585A1 (no)
NO (1)	NO996519L (no)
NZ (1)	NZ501249A (no)
OA (1)	OA11247A (no)
PA (1)	PA8454201A1 (no)
PE (1)	PE84399A1 (no)
PL (1)	PL337799A1 (no)
PT (1)	PT1007024E (no)
SI (1)	SI1007024T1 (no)
SK (1)	SK173299A3 (no)
TN (1)	TNSN98122A1 (no)
TR (1)	TR199903295T2 (no)
TW (1)	TW575437B (no)
UA (1)	UA63953C2 (no)
UY (1)	UY25068A1 (no)
WO (1)	WO1999001122A1 (no)
ZA (1)	ZA985710B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN100444830C (zh)	1998-11-02	2008-12-24	伊兰公司，Plc	多颗粒改进释放组合物
SK286865B6 (sk) *	1999-05-20	2009-06-05	Elan Pharma International Limited	Multičasticový farmaceutický prostriedok s riadeným uvoľňovaním selektívneho inhibítora spätného príjmu serotonínu a jeho použitie
IE990406A1 (en)	1999-05-20	2000-12-27	Elan Corp Plc	Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
DE60026146T2 (de)	1999-09-03	2006-08-17	Apbi Holdings, Llc	Verwendung von Dapoxetin, A selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Disfunktion
ES2168043B1 (es) *	1999-09-13	2003-04-01	Esteve Labor Dr	Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
CA2397832C (en) *	2000-02-10	2009-11-03	Bpsi Holdings, Inc.	Acrylic enteric coating compositions
CA2420535A1 (en)	2000-08-30	2002-03-07	Mary Tanya Am Ende	Sustained release formulations for growth hormone secretagogues
US6482440B2 (en) *	2000-09-21	2002-11-19	Phase 2 Discovery, Inc.	Long acting antidepressant microparticles
WO2002080887A2 (en) *	2001-04-10	2002-10-17	Sun Pharmaceutical Industries Limited	Timed pulse release composition
WO2003013480A1 (en) *	2001-08-06	2003-02-20	Dr. Reddy's Laboratories Ltd.	Improved enteric formulation of fluoxetin
GB0607534D0 (en) *	2006-04-13	2006-05-24	Univ London Pharmacy	Colonic drug delivery formulation
EP2586429A1 (en) *	2011-10-26	2013-05-01	Freund Pharmatec Ltd.	Multi-unit drug delivery device for pulsatile or sustained release
CN108014087A (zh) *	2017-12-27	2018-05-11	江苏联环药业股份有限公司	一种盐酸舍曲林胶囊的制备方法
CN109432038A (zh) *	2018-12-28	2019-03-08	乐普制药科技有限公司	一种含有盐酸舍曲林的肠溶片剂及其制备方法
CN114129540B (zh) *	2021-11-19	2022-07-05	浙江维康药业股份有限公司	一种肝苏胶囊及其制作方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK150008C (da) *	1981-11-20	1987-05-25	Benzon As Alfred	Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4803076A (en) *	1986-09-04	1989-02-07	Pfizer Inc.	Controlled release device for an active substance
EP0357364B1 (en) *	1988-08-30	1993-07-28	E.I. Du Pont De Nemours And Company	A process for flash-spinning dry polymeric plexifilamentary film-fibril strands
IL91398A (en) *	1988-08-30	1994-05-30	Pfizer	Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US4983401A (en) *	1989-05-22	1991-01-08	Kinaform Technology, Inc.	Sustained release pharmaceutical preparations having pH controlled membrane coatings

1998
- 1998-06-16 BR BR9809895-0A patent/BR9809895A/pt not_active Application Discontinuation
- 1998-06-16 DK DK98923022T patent/DK1007024T3/da active
- 1998-06-16 JP JP50677799A patent/JP3786715B2/ja not_active Expired - Fee Related
- 1998-06-16 CN CNB988064294A patent/CN1151783C/zh not_active Expired - Fee Related
- 1998-06-16 AT AT98923022T patent/ATE245415T1/de not_active IP Right Cessation
- 1998-06-16 IL IL15230498A patent/IL152304A0/xx unknown
- 1998-06-16 HU HU0301787A patent/HUP0301787A3/hu unknown
- 1998-06-16 IL IL13308198A patent/IL133081A/xx not_active IP Right Cessation
- 1998-06-16 TR TR1999/03295T patent/TR199903295T2/xx unknown
- 1998-06-16 SK SK1732-99A patent/SK173299A3/sk unknown
- 1998-06-16 CN CNA200310118311XA patent/CN1494899A/zh active Pending
- 1998-06-16 CN CNA031489729A patent/CN1475208A/zh active Pending
- 1998-06-16 NZ NZ501249A patent/NZ501249A/en unknown
- 1998-06-16 EP EP98923022A patent/EP1007024B1/en not_active Expired - Lifetime
- 1998-06-16 DE DE69816624T patent/DE69816624T2/de not_active Expired - Fee Related
- 1998-06-16 EA EA199900965A patent/EA001906B1/ru unknown
- 1998-06-16 ES ES98923022T patent/ES2202858T3/es not_active Expired - Lifetime
- 1998-06-16 KR KR10-1999-7011529A patent/KR100369698B1/ko not_active Expired - Fee Related
- 1998-06-16 CA CA002290969A patent/CA2290969C/en not_active Expired - Fee Related
- 1998-06-16 ID IDW991698A patent/ID23187A/id unknown
- 1998-06-16 AU AU75451/98A patent/AU727152B2/en not_active Ceased
- 1998-06-16 CN CNA031489737A patent/CN1475209A/zh active Pending
- 1998-06-16 WO PCT/IB1998/000937 patent/WO1999001122A1/en not_active Ceased
- 1998-06-16 UA UA99116392A patent/UA63953C2/uk unknown
- 1998-06-16 SI SI9830494T patent/SI1007024T1/xx unknown
- 1998-06-16 PT PT98923022T patent/PT1007024E/pt unknown
- 1998-06-16 PL PL98337799A patent/PL337799A1/xx unknown
- 1998-06-25 PA PA19988454201A patent/PA8454201A1/es unknown
- 1998-06-25 TW TW087110269A patent/TW575437B/zh active
- 1998-06-25 AP APAP/P/1998/001278A patent/AP1199A/en active
- 1998-06-26 PE PE1998000577A patent/PE84399A1/es not_active Application Discontinuation
- 1998-06-29 UY UY25068A patent/UY25068A1/es not_active IP Right Cessation
- 1998-06-29 GT GT199800091A patent/GT199800091A/es unknown
- 1998-06-30 DZ DZ980157A patent/DZ2547A1/xx active
- 1998-06-30 TN TNTNSN98122A patent/TNSN98122A1/fr unknown
- 1998-06-30 HN HN1998000099A patent/HN1998000099A/es unknown
- 1998-06-30 MA MA25144A patent/MA24585A1/fr unknown
- 1998-06-30 ZA ZA9805710A patent/ZA985710B/xx unknown
- 1998-07-01 HR HR980376A patent/HRP980376B1/xx not_active IP Right Cessation
1999
- 1999-11-23 IS IS5267A patent/IS5267A/is unknown
- 1999-11-23 BG BG103916A patent/BG64742B1/bg unknown
- 1999-12-23 OA OA9900307A patent/OA11247A/en unknown
- 1999-12-28 NO NO996519A patent/NO996519L/no not_active Application Discontinuation
2003
- 2003-02-05 AR ARP030100364A patent/AR038394A2/es active IP Right Grant

Also Published As

Publication number	Publication date
AR038394A2 (es)	2005-01-12
IL152304A0 (en)	2003-05-29
JP2000513751A (ja)	2000-10-17
EA001906B1 (ru)	2001-10-22
EP1007024B1 (en)	2003-07-23
BG64742B1 (bg)	2006-02-28
HUP0301787A2 (hu)	2003-11-28
GT199800091A (es)	1999-12-21
AU727152B2 (en)	2000-12-07
IL133081A0 (en)	2001-03-19
TNSN98122A1 (fr)	2005-03-15
AP1199A (en)	2003-08-28
UA63953C2 (uk)	2004-02-16
KR100369698B1 (ko)	2003-01-30
HN1998000099A (es)	1998-10-22
KR20010013522A (ko)	2001-02-26
EA199900965A1 (ru)	2000-08-28
CN1475209A (zh)	2004-02-18
TR199903295T2 (xx)	2000-08-21
HK1027982A1 (en)	2001-02-02
ZA985710B (en)	2000-01-10
CN1475208A (zh)	2004-02-18
AP9801278A0 (en)	1998-06-30
HRP980376A2 (en)	1999-04-30
CN1151783C (zh)	2004-06-02
CN1261273A (zh)	2000-07-26
SI1007024T1 (en)	2003-12-31
WO1999001122A1 (en)	1999-01-14
CA2290969A1 (en)	1999-01-14
JP3786715B2 (ja)	2006-06-14
MA24585A1 (fr)	1998-12-31
PA8454201A1 (es)	2000-09-29
TW575437B (en)	2004-02-11
DZ2547A1 (fr)	2003-02-08
SK173299A3 (en)	2000-11-07
PL337799A1 (en)	2000-09-11
HUP0301787A3 (en)	2005-04-28
EP1007024A1 (en)	2000-06-14
BG103916A (en)	2000-07-31
ATE245415T1 (de)	2003-08-15
ID23187A (id)	2000-03-23
NZ501249A (en)	2001-06-29
PE84399A1 (es)	1999-09-11
CN1494899A (zh)	2004-05-12
HRP980376B1 (en)	2002-12-31
ES2202858T3 (es)	2004-04-01
DE69816624T2 (de)	2004-02-19
UY25068A1 (es)	2000-12-29
NO996519D0 (no)	1999-12-28
AU7545198A (en)	1999-01-25
CA2290969C (en)	2004-02-17
OA11247A (en)	2002-11-19
BR9809895A (pt)	2000-08-01
IL133081A (en)	2005-09-25
DE69816624D1 (de)	2003-08-28
IS5267A (is)	1999-11-23
PT1007024E (pt)	2003-11-28
DK1007024T3 (da)	2003-11-17

Publication	Publication Date	Title
NO996518L (no)	2000-02-29	Sertralinsalter og doseringsformer av sertralin med vedvarende frigjøring
DK0914119T3 (da)	2005-01-31	Fremgangsmåde til fremstilling af faste orale dosisformer af valsartan
BR9708585A (pt)	1999-08-03	Forma de dosagem sólida Ph-independente de liberação imediata da cisaprida
EP1019100A4 (en)	2010-01-27	TAXED ACTIVE SUBSTITUTES
FI972555L (fi)	1997-06-16	Päällystettyjen tablettien valmistus
DK0682945T3 (da)	1999-12-13	Oralt præparat med forsinket frigivelse
ATE253371T1 (de)	2003-11-15	Formulierungen von clarithromycin mit verlängerter wirkstoff-freisetzung
ID25792A (id)	2000-11-02	Antibodi-antibodi terhadap cd40 manusia
DK0758244T3 (da)	2002-02-11	Doseringsformer af azithromycin med styret frigivelse
EE200000383A (et)	2001-12-17	Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
NO996519L (no)	2000-02-29	Doseringsformer av sertralin med forsinket frigjøring
NO20002126D0 (no)	2000-04-26	Formulering med forlenget frigjøring
EP1225971A4 (en)	2010-04-07	CONTROLLED RELEASE OF SUBSTANCES
NO20016151D0 (no)	2001-12-17	Fremstilling av substituerte piperidin-4-oner
DE69518193D1 (de)	2000-09-07	Präparat mit verzörgerter Wirkstoffabgabe
IS5266A (is)	1999-11-23	Gelatínhúðuð lausnar skammtaform af sertralíni
NO991148L (no)	1999-03-10	Fremstilling av 1-butyl-4-piperidinyl-metylamin
ZA985707B (en)	2000-01-10	Sertraline salts and sustained-release dosage forms of sertraline.
ATA25797A (de)	1998-10-15	Bergetuch
NO971030L (no)	1997-03-06	Preparat med langvarig frigjöring
PT941075E (pt)	2003-07-31	Forma de dosagem farmaceutica de libertacao rapida e dissimulada do sabor
FIU990032U0 (fi)	1999-01-22	Hirsikerautapari
BR9704505A (pt)	1999-01-19	Chuveiro para higiene íntima
SI0980241T1 (en)	2004-04-30	Gelatine encapsulated solution dosage forms of sertraline

Legal Events

Date	Code	Title	Description
2008-01-21	FC2A	Withdrawal, rejection or dismissal of laid open patent application